Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Big Techs and startupsin pharmaceutical R&D – A 2020perspective on artificial intelligence
0
Zitationen
5
Autoren
2021
Jahr
Abstract
We investigated what kind of artificial intelligence (AI) technologies are utilized in pharmaceutical research and development (R&D) and which sources of AI-related competencies can be leveraged by pharmaceutical companies. First, we found that machine learning (ML) is the dominating AI technology currently used in pharmaceutical R&D. Second, both Big Techs and AI startups are competent knowledge bases for AI applications. Big Techs have long-lasting experience in the digital field and offer more general IT solutions to support pharmaceutical companies in cloud computing, health monitoring, diagnostics or clinical trial management, whereas startups can provide more specific AI services to address special issues in the drug-discovery space.
Ähnliche Arbeiten
The Coding Manual for Qualitative Researchers
2025 · 17.900 Zit.
Research methods for business: A skill building approach
1993 · 17.078 Zit.
The NIST definition of cloud computing
2011 · 11.596 Zit.
The DeLone and McLean Model of Information Systems Success: A Ten-Year Update
2003 · 11.240 Zit.
Introduction to Information Retrieval
2008 · 10.770 Zit.